Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05784415 · ClinicalTrials.gov registry record

Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell

A clinical trial, sponsored by AIDS Malignancy Consortium.

Completed
Registry status
30
Enrollment target

NCT05784415 is a clinical trial that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05784415 has completed, sponsored by AIDS Malignancy Consortium.

COMPLETED
Registry status
30 participants
Enrollment target

Study Summary

This protocol will develop an observational cohort of PLWH who have been or are being treated with CAR19 therapy outside of an AMC clinical trial. Following regulatory approval of this protocol, sites will be asked to capture information of participants, who carry a diagnosis of HIV disease AND received CAR19 therapy outside of a clinical trial between August 30, 2017 and August 31, 2021. Data captured will include data points are available as part of standard of care for participants undergoing CAR19 therapy. AMC investigators, as well as non-AMC investigators will identify eligible participants to the CIBMTR, who in turn will provide the AMC statistical center with de-identified data

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-05-22
Est. Completion 2024-11-14

Sponsor

AIDS Malignancy Consortium

45 total trials

What the Registry Record Tells You About NCT05784415

The ClinicalTrials.gov registry entry for NCT05784415 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AIDS Malignancy Consortium, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05784415 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05784415 about?

NCT05784415 is a clinical study titled "Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell". This protocol will develop an observational cohort of PLWH who have been or are being treated with CAR19 therapy outside of an AMC clinical trial. Following regulatory approval of this protocol, sites will be asked to capture information of participants, who carry a diagnosis of HIV disease AND rece...

What is the current status of trial NCT05784415?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-05-22. Estimated completion is 2024-11-14.

Who is sponsoring clinical trial NCT05784415?

This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.